1887

Abstract

Epstein–Barr virus (EBV) HI-A rightward transcripts (BARTs; also designated complementary strand transcripts or CSTs) have been demonstrated to contain several splicing forms in EBV-infected cells. To date, however, little is known about the actual full-length splicing form and its functions. In the present study, we proved that six forms of BARTs were present in EBV-positive cell lines and various tissue specimens with different EBV infection patterns. Of the BART-encoded genes, mRNA of four major splicing forms, including BARF0, RPMS1, RPMS1A and A73, were expressed in all EBV-infected cells. On the other hand, mRNA of two minor splicing forms, RK-BARF0 and RB3, was rarely detected, or if at all, at very low expression levels. Both RPMS1A and RPMS1 mRNA was transcribed at higher levels in EBV-infected cells. In particular, RPMS1 mRNA was expressed abundantly in epithelial carcinoma cells, including gastric carcinoma and nasopharyngeal carcinoma, in association with a lytic infection signal, BZLF1 mRNA. The four major splicing forms were expressed much less in B-cell lines with an integrated EBV genome than in those with episomal EBV genomes. These data indicate that at least six splicing forms can be expressed by EBV-infected cells or tissues, although the expression patterns or levels differ for different infection states such as lytic and latent infections.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.044727-0
2012-10-01
2020-07-12
Loading full text...

Full text loading...

/deliver/fulltext/jmm/61/10/1445.html?itemId=/content/journal/jmm/10.1099/jmm.0.044727-0&mimeType=html&fmt=ahah

References

  1. Baer R., Bankier A. T., Biggin M. D., Deininger P. L., Farrell P. J., Gibson T. J., Hatfull G., Hudson G. S., Satchwell S. C. other authors 1984; DNA sequence and expression of the B95-8 Epstein–Barr virus genome. Nature 310:207–211 [CrossRef][PubMed]
    [Google Scholar]
  2. Brooks L. A., Lear A. L., Young L. S., Rickinson A. B. 1993; Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. J Virol 67:3182–3190[PubMed]
    [Google Scholar]
  3. Cai X., Schäfer A., Lu S., Bilello J. P., Desrosiers R. C., Edwards R., Raab-Traub N., Cullen B. R. 2006; Epstein–Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23 [CrossRef][PubMed]
    [Google Scholar]
  4. Chen H. L., Lung M. M., Sham J. S., Choy D. T., Griffin B. E., Ng M. H. 1992; Transcription of BamHI-A region of the EBV genome in NPC tissues and B cells. Virology 191:193–201 [CrossRef][PubMed]
    [Google Scholar]
  5. Chen H., Smith P., Ambinder R. F., Hayward S. D. 1999; Expression of Epstein-Barr virus BamHI-A rightward transcripts in latently infected B cells from peripheral blood. Blood 93:3026–3032[PubMed]
    [Google Scholar]
  6. Chen H., Huang J., Wu F. Y., Liao G., Hutt-Fletcher L., Hayward S. D. 2005; Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. J Virol 79:1724–1733 [CrossRef][PubMed]
    [Google Scholar]
  7. Chevallier-Greco A., Manet E., Chavrier P., Mosnier C., Daillie J., Sergeant A. 1986; Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5:3243–3249[PubMed]
    [Google Scholar]
  8. Chien Y. C., Chen J. Y., Liu M. Y., Yang H. I., Hsu M. M., Chen C. J., Yang C. S. 2001; Serologic markers of Epstein–Barr virus infection and nasopharyngeal carcinoma in Taiwanese men. N Engl J Med 345:1877–1882 [CrossRef][PubMed]
    [Google Scholar]
  9. Daibata M., Taguchi T., Nemoto Y., Saito T., Machida H., Imai S., Miyoshi I., Taguchi H. 2002; Epstein–Barr virus (EBV)-positive pyothorax-associated lymphoma (PAL): chromosomal integration of EBV in a novel CD2-positive PAL B-cell line. Br J Haematol 117:546–557 [CrossRef][PubMed]
    [Google Scholar]
  10. de Jesus O., Smith P. R., Spender L. C., Elgueta Karstegl C., Niller H. H., Huang D., Farrell P. J. 2003; Updated Epstein–Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. J Gen Virol 84:1443–1450 [CrossRef][PubMed]
    [Google Scholar]
  11. Edwards R. H., Marquitz A. R., Raab-Traub N. 2008; Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing. J Virol 82:9094–9106 [CrossRef][PubMed]
    [Google Scholar]
  12. Fries K. L., Sculley T. B., Webster-Cyriaque J., Rajadurai P., Sadler R. H., Raab-Traub N. 1997; Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J Virol 71:2765–2771[PubMed]
    [Google Scholar]
  13. Gilligan K. J., Rajadurai P., Lin J. C., Busson P., Abdel-Hamid M., Prasad U., Tursz T., Raab-Traub N. 1991; Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo. J Virol 65:6252–6259[PubMed]
    [Google Scholar]
  14. Hitt M. M., Allday M. J., Hara T., Karran L., Jones M. D., Busson P., Tursz T., Ernberg I., Griffin B. E. 1989; EBV gene expression in an NPC-related tumour. EMBO J 8:2639–2651[PubMed]
    [Google Scholar]
  15. Hoshikawa Y., Satoh Y., Murakami M., Maeta M., Kaibara N., Ito H., Kurata T., Sairenji T. 2002; Evidence of lytic infection of Epstein-Barr virus (EBV) in EBV-positive gastric carcinoma. J Med Virol 66:351–359 [CrossRef][PubMed]
    [Google Scholar]
  16. Imai S., Nishikawa J., Takada K. 1998; Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72:4371–4378[PubMed]
    [Google Scholar]
  17. Karran L., Gao Y., Smith P. R., Griffin B. E. 1992; Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells. Proc Natl Acad Sci U S A 89:8058–8062 [CrossRef][PubMed]
    [Google Scholar]
  18. Kienzle N., Sculley T. B., Poulsen L., Buck M., Cross S., Raab-Traub N., Khanna R. 1998; Identification of a cytotoxic T-lymphocyte response to the novel BARF0 protein of Epstein-Barr virus: a critical role for antigen expression. J Virol 72:6614–6620[PubMed]
    [Google Scholar]
  19. Kienzle N., Sculley T. B., Greco S., Khanna R. 1999; Cutting edge: silencing virus-specific cytotoxic T cell-mediated immune recognition by differential splicing: a novel implication of RNA processing for antigen presentation. J Immunol 162:6963–6966[PubMed]
    [Google Scholar]
  20. Lawrence J. B., Villnave C. A., Singer R. H. 1988; Sensitive, high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 52:51–61 [CrossRef][PubMed]
    [Google Scholar]
  21. Lear A. L., Rowe M., Kurilla M. G., Lee S., Henderson S., Kieff E., Rickinson A. B. 1992; The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J Virol 66:7461–7468[PubMed]
    [Google Scholar]
  22. Ooka T., De Turenne M., De The G., Daillie J. 1984; Epstein-Barr virus-specific DNase activity in nonproducer Raji cells after treatment with 12-o-tetradecanoylphorbol-13-acetate and sodium butyrate. J Virol 49:626–628[PubMed]
    [Google Scholar]
  23. Parker B. D., Bankier A., Satchwell S., Barrell B., Farrell P. J. 1990; Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339–346 [CrossRef][PubMed]
    [Google Scholar]
  24. Pfeffer S., Zavolan M., Grässer F. A., Chien M., Russo J. J., Ju J., John B., Enright A. J., Marks D. other authors 2004; Identification of virus-encoded microRNAs. Science 304:734–736 [CrossRef][PubMed]
    [Google Scholar]
  25. Rickinson A. B., Kieff E. 2001; Epstein-Barr Virus. In Fields Virology pp. 2575–2627 Philadelphia, PA: Lippincott-Raven;
    [Google Scholar]
  26. Sadler R. H., Raab-Traub N. 1995; Structural analyses of the Epstein-Barr virus BamHI A transcripts. J Virol 69:1132–1141[PubMed]
    [Google Scholar]
  27. Smith P. R. 2001; Epstein–Barr virus complementary strand transcripts (CSTs/BARTs) and cancer. Semin Cancer Biol 11:469–476 [CrossRef][PubMed]
    [Google Scholar]
  28. Smith P. R., Gao Y., Karran L., Jones M. D., Snudden D., Griffin B. E. 1993; Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol 67:3217–3225[PubMed]
    [Google Scholar]
  29. Smith P. R., de Jesus O., Turner D., Hollyoake M., Karstegl C. E., Griffin B. E., Karran L., Wang Y., Hayward S. D., Farrell P. J. 2000; Structure and coding content of CST (BART) family RNAs of Epstein-Barr virus. J Virol 74:3082–3092 [CrossRef][PubMed]
    [Google Scholar]
  30. Speck S. H., Chatila T., Flemington E. 1997; Reactivation of Epstein–Barr virus: regulation and function of the BZLF1 gene. Trends Microbiol 5:399–405 [CrossRef][PubMed]
    [Google Scholar]
  31. Takakuwa T., Luo W. J., Ham M. F., Mizuki M., Iuchi K., Aozasa K. 2003; Establishment and characterization of unique cell lines derived from pyothorax-associated lymphoma which develops in long-standing pyothorax and is strongly associated with Epstein-Barr virus infection. Cancer Sci 94:858–863 [CrossRef][PubMed]
    [Google Scholar]
  32. Yamamoto T., Tsuji K., Suzuki D., Morizane S., Iwatsuki K. 2007; A novel, noninvasive diagnostic probe for hydroa vacciniforme and related disorders: detection of latency-associated Epstein-Barr virus transcripts in the crusts. J Microbiol Methods 68:403–407 [CrossRef][PubMed]
    [Google Scholar]
  33. Zhang C. X., Ooka T. 1995; Expression of the complementary-strand transcripts from BamHI-A region of the Epstein-Barr virus genome in various induced virus-carrying B cell lines. Virology 208:180–188 [CrossRef][PubMed]
    [Google Scholar]
  34. Zhang J., Chen H., Weinmaster G., Hayward S. D. 2001; Epstein-Barr virus BamHI-A rightward transcript-encoded RPMS protein interacts with the CBF1-associated corepressor CIR to negatively regulate the activity of EBNA2 and NotchIC. J Virol 75:2946–2956 [CrossRef][PubMed]
    [Google Scholar]
  35. zur Hausen H., O’Neill F. J., Freese U. K., Hecker E. 1978; Persisting oncogenic herpesvirus induced by the tumour promotor TPA. Nature 272:373–375 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.044727-0
Loading
/content/journal/jmm/10.1099/jmm.0.044727-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error